ANGIODYNAMICS INC - Form 4 Filing

Karen A. Licitra, a director at AngioDynamics Inc., acquired 11,887 shares of common stock on July 15, 2026, through the grant of restricted stock units. These units were awarded as annual compensation for her services as a director and vested immediately upon grant. The acquisition of these shares, valued at a nominal price of $0.00, resulted in a post-transaction ownership of 102,322 shares. This transaction is reported on Form 4 and was signed on July 22, 2026, by Lawrence T. Weiss as Attorney in Fact. The filing details indicate that the reported shares are held directly.